Suzanne M. Hanlon serves as Executive at Zynerba Pharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, Suzanne M. Hanlon has executed 4 insider transactions totaling $107.4K, demonstrating a bullish approach to their equity position. Their most recent transaction on Jan 21, 2021 involved receiving (via award) 37,000 shares valued at $0.
Suzanne M. Hanlon currently holds 80,693 shares of Zynerba Pharmaceuticals, Inc. (ZYNE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Suzanne M. Hanlon has been a net buyer of ZYNE stock. They have purchased $75.8K and sold $31.6K worth of shares.
Suzanne M. Hanlon's most recent insider trade was on Jan 21, 2021, when they sold 37,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $5.80 |
| Discretionary |
| Aug 16, 2016 | ZYNE | $31.6K | Sale | 3,000 | $10.53 | Discretionary |
| Aug 5, 2015 | ZYNE | $53.8K | Purchase | 3,000 | $17.92 | Discretionary |